Filing Details

Accession Number:
0000875320-25-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-12 16:29:52
Reporting Period:
2025-02-10
Filing Date:
2025-02-12
Accepted Time:
2025-02-12 16:29:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1914164 Iii Morrow Edward Atkinson C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Chief Technical Ops. Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-02-10 876 $467.98 24,972 No 4 F Direct
Common Stock Disposition 2025-02-11 1,747 $459.83 23,225 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024.